3.0
6 June 2026
Current employee, more than 8 years
Recommend
CEO approval
Business outlook
Pros
- exciting technology - incredibly smart scientists - opportunity to be at forefront of exciting new therapeutics
Cons
- shifting budgets and priorities on a quarterly basis, makes it difficult to execute long term strategic plans (especially if a quarter has poor performance due to constant restructuring)